TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event

Risk & Weakness

Pradeep Bonde: 4% Breakout Bearish

34 Findings · last calculated November 2, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Methodology & criteria

Bonde's downside counterpart (original Stockbee formula 'c/c1 ≤ 0.96'): a daily loss of at least 4% on above-average volume (relative volume above 1) — a downside momentum burst that often triggers further weak days. Minimum daily volume 100,000 shares, price above $3 (penny-stock filter).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(16)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Breakout
The price clears a level where it previously failed multiple times (top of a base, an old high) - ideally on clearly elevated volume. For many momentum strategies, the breakout is the actual buy signal.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Momentum
The driving force behind a price trend: stocks that have recently risen sharply statistically tend to keep rising more often than not. Momentum strategies therefore buy strength - not perceived bargains.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.

View all terms in the Scanner Glossary

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Pradeep Bonde: 4% Breakout Bearish
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
DFTX Definium Therapeutics, Inc. 07/30 +332 % 72 % Stage 2 D 26 1 of 9 4.8 $ Biotechnology Neutral
Read
— Healthcare 36.30 $ +170.2 % +246.6 % +194.0 % −4.7 % +99.9 % 98 50 14.0 % 8.8 % 2.19 — 0.0 — 17.9 — — 0.0 0.0 % — 0.0 % -94.7 % -20.6 % — 69.5 % — — 0.0 % 0.0 % 1.4 65.6 % 7.5 % 4.7 (19)
HYLN Hyliion Holdings Corp. 08/11 +90 % ⚠ Wildest 10% 98 % Stage 2 C 54 4 of 9 0.6 $ Auto Parts Uses AI
Read
— Consumer Cyclical 3.30 $ +231.5 % +141.9 % +51.1 % −42.8 % +134.8 % 98 50 13.6 % 15.8 % 3.57 — 0.0 64.0 — — — -0.8 -481.7 % 6.5 % 0.0 % -25.2 % -18.3 % — 95.3 % +130.3 % 6 0.0 % 0.0 % 21.4 25.2 % 10.7 % 3.0 (1)
HYMC Hycroft Mining Holding Corporation 07/29 +212 % ⚠ Wildest 10% 112 % Stage 1 D 35 4 of 9 1.5 $ Gold Neutral — — Basic Materials 16.40 $ -2.7 % -6.3 % +120.8 % −62.7 % +40.8 % 97 42 8.2 % 8.0 % 2.79 — 0.0 — 7.1 — — -0.8 — -405.6 % 0.0 % -86.1 % -26.9 % 0.00 — -100.0 % 3 0.0 % 0.0 % 0.6 33.1 % 22.5 % 4.0 (2)
ABSI Absci Corp 08/11 +106 % ⚠ Wildest 10% 102 % Stage 2 D 34 3 of 9 1.9 $ Biotechnology Sells AI — — Healthcare 11.10 $ +112.3 % +218.8 % +176.9 % −9.2 % +25.2 % 96 42 16.7 % 12.8 % 2.28 — 0.0 1,200.0 8.8 — — -0.4 — -5,395.6 % 0.0 % -63.9 % -34.1 % 0.03 — -38.2 % 4 0.0 % 0.0 % -0.3 72.9 % 26.2 % 4.6 (11)
MEI Methode Electronics Inc — -18 % ⚠ Wildest 10% 96 % Stage 2 D 43 3 of 9 0.5 $ Electronic Components Uses AI
Read
— Technology 14.70 $ +104.6 % +185.0 % +130.0 % −2.3 % +78.9 % 94 2 13.1 % 9.7 % 1.57 — 10.2 0.5 0.8 — 0.78 10.2 — 19.8 % -3.5 % -9.3 % 0.5 % 0.52 — -2.8 % 4 1.7 % 36.4 % 7.2 93.1 % 8.8 % 3.8 (4)
TMCI Treace Medical Concepts Inc 08/06 -28 % ⚠ Wildest 10% 89 % Stage 3 D 39 4 of 9 0.3 $ Medical Devices Neutral
Read
— Healthcare 4.40 $ +83.3 % +75.0 % -22.8 % −42.8 % +19.6 % 94 42 10.5 % 9.8 % 1.49 — 0.0 1.2 3.5 — — -40.9 — 79.5 % -29.0 % -66.9 % -17.3 % 0.18 — +1.6 % 3 0.0 % 0.0 % 0.4 57.1 % 3.8 % 3.2 (5)
BCAX Bicara Therapeutics Inc. 08/11 — 80 % Stage 2 D 29 1 of 9 0.6 $ Biotechnology – — — Healthcare 9.10 $ +48.5 % +69.9 % -38.7 % −5.8 % +263.9 % 92 42 6.8 % 5.8 % -0.69 — 0.0 — 1.2 — — 0.0 — — 0.0 % -32.3 % -26.1 % 0.00 — — 4 0.0 % 0.0 % 18.5 104.3 % 22.5 % 4.6 (14)
FDMT 4D Molecular Therapeutics Inc 08/10 -22 % 76 % Stage 3 C 49 4 of 9 0.6 $ Biotechnology – — — Healthcare 11.90 $ +54.7 % +59.0 % +12.0 % −6.7 % +136.1 % 89 50 10.5 % 8.5 % 2.74 — 0.0 6.8 1.7 — — -3.6 — -157.7 % -194.7 % -34.9 % -25.1 % 0.05 — +230,194.6 % 6 0.0 % 0.0 % 8.4 98.4 % 23.9 % 4.7 (12)
AVBP ArriVent BioPharma, Inc. 08/10 — ⚠ Wildest 10% 92 % Stage 2 D 37 2 of 9 0.7 $ Biotechnology – — — Healthcare 14.90 $ +67.7 % +54.2 % -14.6 % −2.6 % +64.3 % 87 42 6.0 % 5.9 % 1.35 — 0.0 — 2.1 — — 0.0 — — 0.0 % -55.2 % -33.1 % 0.00 — — 2 0.0 % 0.0 % 15.6 95.9 % 18.2 % 5.0 (11)
RAL Ralliant Corporation 08/10 — 55 % Stage 2 D 40 4 of 9 7.4 $ Electronic Components – — — Technology 67.20 $ +36.2 % +40.5 % +62.4 % −2.5 % +17.8 % 83 50 3.8 % 3.7 % — — 21.6 3.4 4.9 22.8 — 13.0 12.7 % 50.9 % -56.4 % -45.9 % 3.9 % 0.73 42.4 % -4.0 % 2 0.3 % 11.4 % 1.3 102.0 % 6.7 % 4.1 (11)
BEAM Beam Therapeutics Inc 08/04 +2 % 71 % Stage 2 C 50 4 of 9 2.9 $ Biotechnology – — — Healthcare 27.20 $ +19.8 % +24.2 % +16.4 % −8.0 % +71.2 % 83 42 7.7 % 7.2 % 2.20 — 0.0 18.3 2.4 — — -7.0 -337.8 % -161.9 % -55.5 % -5.8 % -17.0 % 0.22 78.6 % +120.0 % 4 0.0 % 0.0 % 8.3 107.0 % 39.3 % 4.7 (15)
ADAM New York Mortgage Trust, Inc. 07/29 +12 % 33 % Stage 2 C 54 3 of 9 0.6 $ REIT - Mortgage – — — Real Estate 6.50 $ +32.3 % +37.9 % +18.3 % −2.0 % +76.9 % 79 50 3.1 % 2.6 % 1.30 6.0 6.9 — 0.7 5.2 2.50 0.0 — 55.1 % -1.1 % 13.0 % 0.3 % 7.66 — +44.1 % 6 18.3 % 92.0 % -0.4 56.5 % 4.3 % 3.4 (7)
ACHV Achieve Life Sciences Inc 08/06 -5 % 81 % Stage 2 D 27 3 of 9 0.7 $ Biotechnology – — — Healthcare 6.80 $ +0.8 % +39.7 % +45.3 % −7.5 % +108.1 % 79 42 8.7 % 8.2 % 2.31 — 35.3 — — — 17.68 -2.4 — — 0.0 % -496.2 % -29.2 % — — -100.0 % — 0.0 % 0.0 % -29.4 61.0 % 17.4 % 4.8 (12)
WNC Wabash National Corporation 07/24 -16 % 57 % Stage 2 D 33 2 of 9 0.5 $ Farm & Heavy Construction Machinery – — — Industrials 11.70 $ +48.3 % +56.9 % +64.4 % −0.6 % +73.1 % 78 97 9.6 % 6.9 % 1.47 — 8.6 0.3 1.4 — 0.73 2.0 — 1.0 % -5.5 % -17.8 % -3.2 % 1.66 — -20.8 % 5 2.5 % 7.9 % 4.6 100.8 % 10.5 % 4.5 (2)
MARA Marathon Digital Holdings Inc 08/04 +5 % ⚠ Wildest 10% 84 % Stage 3 D 27 4 of 9 2.6 $ Capital Markets – — — Financial Services 6.80 $ +63.7 % +41.1 % -62.1 % −40.8 % +149.4 % 76 84 10.0 % 8.7 % 5.35 — 39.5 3.3 1.1 — 0.10 6.7 -558.1 % 40.1 % 0.0 % -67.3 % -26.3 % 1.15 45.1 % +38.2 % 3 0.0 % 0.0 % 1.6 69.6 % 29.8 % 3.9 (15)
PTCT PTC Therapeutics Inc 08/06 +33 % 41 % Stage 2 C 48 2 of 9 5.0 $ Biotechnology – — — Healthcare 60.00 $ +8.1 % +4.1 % -4.3 % −3.4 % +55.3 % 75 42 4.7 % 4.0 % 0.49 — 22.3 4.3 1,259.2 — 0.81 20.5 16.5 % 50.0 % -3.8 % -7,740.1 % 2.5 % -2.19 -6.3 % +114.5 % 8 0.0 % 0.0 % 2.5 117.7 % 14.9 % 4.3 (16)
NPCE Neuropace Inc 08/11 +85 % 59 % Stage 2 C 53 2 of 9 0.4 $ Medical Devices – — — Healthcare 12.30 $ +3.1 % +2.1 % +28.4 % −16.5 % +53.8 % 74 50 4.7 % 4.7 % 1.87 — 158.7 4.2 33.0 — — -16.9 — 77.4 % -17.9 % -111.4 % -7.5 % 4.88 — +25.1 % 4 0.0 % 0.0 % -11.4 96.3 % 3.0 % 4.9 (10)
SI Shoulder Innovations, Inc. — — 65 % Stage 2 C 46 — 0.4 $ – — — — 19.10 $ +34.9 % +37.9 % +74.4 % −56.1 % +36.6 % 70 42 9.0 % 6.8 % — — 0.0 — 3.0 — — 0.0 — 0.0 % 0.0 % 0.0 % 0.0 % — — — 3 0.0 % 0.0 % — 0.0 % — 4.8 (4)
HROW Harrow Health Inc 08/10 +44 % 66 % Stage 3 D 35 2 of 9 1.0 $ Drug Manufacturers - Specialty & Generic – — — Healthcare 28.20 $ -12.7 % -18.0 % -18.5 % −24.3 % +114.3 % 58 26 5.1 % 5.4 % 0.19 — 40.2 3.8 37.8 209.6 — 114.4 — 73.3 % -13.5 % -35.4 % -0.4 % 10.47 — +36.4 % 8 0.0 % 0.0 % 4.2 58.9 % 23.0 % 5.0 (9)
OLMA Olema Pharmaceuticals Inc 08/10 -15 % ⚠ Wildest 10% 112 % Stage 1 D 26 2 of 9 0.6 $ Biotechnology – — — Healthcare 7.00 $ -57.9 % -55.6 % -15.2 % −68.5 % +386.7 % 54 42 7.7 % 7.0 % 2.01 — 0.0 — 1.3 — — -3.3 — — 0.0 % -42.9 % -31.8 % 0.00 — — 2 0.0 % 0.0 % 12.7 119.4 % 20.4 % 4.7 (12)
COYA Coya Therapeutics, Inc. 08/11 +5 % 59 % Stage 3 C 50 4 of 9 0.1 $ Biotechnology – — — Healthcare 3.60 $ -7.1 % +9.4 % -36.7 % −33.8 % +271.1 % 49 42 7.5 % 7.4 % 0.58 — 0.0 11.5 1.9 — — -6.2 — -111.8 % -270.2 % -51.3 % -32.3 % — — +123.6 % 5 0.0 % 0.0 % 14.4 35.4 % 5.1 % 5.0 (7)
SRI Stoneridge Inc 08/05 -20 % 60 % Stage 2 D 33 3 of 9 0.2 $ Auto Parts – — — Consumer Cyclical 5.70 $ +18.7 % +33.7 % -13.6 % −27.3 % +145.8 % 49 90 5.2 % 5.5 % 1.88 — 20.3 0.2 1.0 — 0.26 15.4 — 19.3 % -13.3 % -53.6 % -1.7 % 1.04 — -5.2 % 3 0.0 % 0.0 % 5.7 84.3 % 3.3 % 3.0 (1)
CD Chaince Digital Holdings Inc. — +5 % ⚠ Wildest 10% 154 % Stage 4 C 47 3 of 9 0.5 $ Capital Markets Neutral
Read
— Financial Services 6.70 $ -5.8 % -20.4 % -31.8 % −88.1 % — 40 42 11.2 % 15.7 % 8.17 — 0.0 196.1 12.1 — — 170.0 — 59.8 % -182.5 % -6.9 % -6.9 % — — +85.3 % 5 0.0 % 0.0 % -17.8 24.1 % 5.4 % —
PESI Perma-Fix Environmental Svcs Inc 08/06 0 % 64 % Stage 4 D 29 3 of 9 0.3 $ Waste Management Neutral — — Industrials 12.50 $ -11.9 % +3.6 % -6.7 % −25.8 % +145.9 % 34 15 7.2 % 7.1 % 0.56 — 99.0 4.6 — — — -31.4 — -2.8 % -37.0 % -28.5 % -12.4 % — — +4.3 % 3 0.0 % 0.0 % -1.0 49.3 % 16.1 % 5.0 (1)
IE Ivanhoe Electric Inc. 08/04 -9 % 77 % Stage 4 C 51 4 of 9 1.2 $ Copper Sells AI
Read
— Basic Materials 7.70 $ -41.5 % -51.9 % -39.9 % −53.1 % +133.9 % 30 50 6.7 % 7.1 % 1.29 — 0.0 408.0 2.1 — — 159.6 -3,259.6 % 58.7 % 0.0 % -2.2 % -15.3 % 0.08 86.0 % +11.8 % 3 0.0 % 0.0 % 12.4 77.4 % 8.9 % 4.3 (4)
ESAB ESAB Corp 08/05 +18 % 46 % Stage 4 C 46 3 of 9 4.4 $ Metal Fabrication – — — Industrials 69.80 $ -13.4 % -13.9 % -34.9 % −28.1 % +68.9 % 25 20 5.7 % 4.8 % 1.14 18.7 10.8 1.5 1.9 22.2 0.69 14.5 13.5 % 37.0 % 5.8 % 11.4 % 5.0 % 0.98 39.0 % +3.7 % 2 0.7 % 8.3 % 6.6 99.8 % 9.4 % 4.7 (11)
LMB Limbach Holdings Inc 08/04 +88 % 79 % Stage 4 C 51 2 of 9 0.6 $ Building Products & Equipment – — — Industrials 48.40 $ +4.6 % -0.9 % -46.1 % −46.8 % +57.6 % 23 50 4.4 % 6.1 % 1.33 — 20.9 0.8 — 11.4 2.29 17.7 — 23.6 % 4.4 % 18.6 % 6.8 % — — +24.7 % 4 0.0 % 0.0 % 7.5 90.5 % 10.0 % 4.2 (5)
METC Ramaco Resources Inc 07/30 +22 % ⚠ Wildest 10% 83 % Stage 4 D 33 3 of 9 0.5 $ Coking Coal Neutral
Read
— Basic Materials 7.10 $ -45.7 % -56.7 % -74.6 % −82.1 % +129.6 % 21 4 6.7 % 7.4 % 1.54 — 5.5 0.9 1.0 — — 1,160.9 -20.0 % 14.3 % -12.0 % -15.2 % -5.3 % 0.95 42.4 % -19.5 % 4 0.0 % 526.4 % 1.4 91.5 % 74.5 % 4.3 (8)
COUR Coursera Inc 07/23 -19 % 56 % Stage 4 D 42 3 of 9 1.0 $ Education & Training Services – — — Consumer Defensive 3.50 $ -26.5 % -24.1 % -44.9 % −57.5 % +69.0 % 10 42 5.5 % 5.6 % 1.25 — 6.1 1.1 — 34.0 — -7.5 — 55.9 % -15.4 % -10.3 % -2.4 % — — +9.0 % 6 0.0 % 0.0 % 5.1 69.9 % 9.8 % 4.0 (11)
PRCT Procept Biorobotics Corp 08/05 -13 % 65 % Stage 4 C 45 2 of 9 1.1 $ Medical Devices – — — Healthcare 19.20 $ -34.5 % -31.3 % -43.5 % −65.4 % +10.1 % 6 42 7.3 % 6.5 % 0.92 — 0.0 3.2 — — — -24.6 — 63.4 % -32.5 % -27.8 % -14.8 % — — +37.2 % 6 0.0 % 0.0 % 4.9 102.4 % 13.5 % 3.5 (15)
MSTR MicroStrategy Incorporated 07/30 +72 % 81 % Stage 4 D 25 4 of 9 49.2 $ Software - Application – — — Technology 130.50 $ -31.7 % -41.6 % -48.7 % −81.3 % +69.2 % 4 7 9.2 % 7.7 % 3.57 — 5.9 98.7 1.0 — 2.85 179.2 -11,641.5 % 67.6 % 0.0 % -30.8 % -38.7 % 0.18 84.1 % +3.0 % 1 0.0 % 0.0 % 6.9 64.0 % 7.3 % 4.8 (16)
ATYR aTyr Pharma, Inc. 08/06 -25 % ⚠ Wildest 10% 113 % Stage 4 D 37 1 of 9 0.5 $ Biotechnology – — — Healthcare 4.90 $ -31.4 % -23.3 % -86.1 % −92.3 % +2,204.1 % 4 42 10.5 % 9.9 % 0.91 — 0.0 — 8.3 — — -0.8 — -24,682.1 % 0.0 % -105.6 % -46.6 % 0.20 — -19.2 % 2 0.0 % 0.0 % -20.5 48.6 % 13.2 % 3.7 (9)
VEEA Veea Inc. 08/18 — ⚠ Wildest 10% 182 % Stage 4 D 37 4 of 9 0.3 $ Information Technology Services – — — Technology 4.80 $ -48.2 % -60.7 % -62.1 % −84.5 % — 3 42 16.5 % 14.0 % 0.28 — 0.0 562.0 — — — 164.5 — 74.3 % 0.0 % 0.0 % -40.6 % — — +56.6 % 1 0.0 % 0.0 % -25.4 3.2 % 2.7 % —
LENZ LENZ Therapeutics Inc 07/29 -23 % ⚠ Wildest 10% 84 % Stage 4 D 30 1 of 9 0.1 $ Biotechnology Neutral
Read
— Healthcare 3.10 $ — — -88.6 % −53.7 % +525.0 % 2 42 7.3 % 6.9 % 1.73 — 0.0 4.8 0.5 — — -8.0 -622.9 % 91.7 % 0.0 % -59.2 % -37.4 % 0.00 93.0 % — 2 0.0 % 0.0 % 3.5 111.8 % 55.3 % 4.4 (7)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Bonde's downside counterpart (original Stockbee formula 'c/c1 ≤ 0.96'): a daily loss of at least 4% on above-average volume (relative volume above 1) — a downside momentum burst that often triggers further weak days. Minimum daily volume 100,000 shares, price above $3 (penny-stock filter).

All scanners are recalculated daily across the entire stock universe — most recently on November 2, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 34 stocks pass this scanner's criteria (as of November 2, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.

This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?